Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-03

Clinical Trial Update: Effects of Ondansetron in Obsessive-compulsive and Tic Disorders [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating ondansetron for obsessive-compulsive disorder and tic disorders (including Tourette syndrome) has completed, with results posted in Jul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

Sponsor: NYU Langone Health | Conditions: Obsessive-Compulsive Disorder, Tic Disorders | Phase 4 | Status: COMPLETED | Results posted: 2023-07-03